Development of an accessible 10-year Digital CArdioVAscular (DiCAVA) risk assessment: a UK Biobank study

• URL: http://arxiv.org/abs/2104.10079v1
• Date: Tue, 20 Apr 2021 16:01:50 GMT
• Title: Development of an accessible 10-year Digital CArdioVAscular (DiCAVA) risk assessment: a UK Biobank study
• Authors: Nikola Dolezalova, Angus B. Reed, Alex Despotovic, Bernard Dillon Obika, Davide Morelli, Mert Aral, David Plans
• Abstract summary: The aim was to develop a new risk model (DiCAVA) using statistical and machine learning techniques. A secondary goal was to identify new patient-centric variables that could be incorporated into CVD risk assessments.
• Score: 0.46180371154032895
• License: http://creativecommons.org/licenses/by-nc-nd/4.0/
• Abstract: Background: Cardiovascular diseases (CVDs) are among the leading causes of death worldwide. Predictive scores providing personalised risk of developing CVD are increasingly used in clinical practice. Most scores, however, utilise a homogenous set of features and require the presence of a physician. Objective: The aim was to develop a new risk model (DiCAVA) using statistical and machine learning techniques that could be applied in a remote setting. A secondary goal was to identify new patient-centric variables that could be incorporated into CVD risk assessments. Methods: Across 466,052 participants, Cox proportional hazards (CPH) and DeepSurv models were trained using 608 variables derived from the UK Biobank to investigate the 10-year risk of developing a CVD. Data-driven feature selection reduced the number of features to 47, after which reduced models were trained. Both models were compared to the Framingham score. Results: The reduced CPH model achieved a c-index of 0.7443, whereas DeepSurv achieved a c-index of 0.7446. Both CPH and DeepSurv were superior in determining the CVD risk compared to Framingham score. Minimal difference was observed when cholesterol and blood pressure were excluded from the models (CPH: 0.741, DeepSurv: 0.739). The models show very good calibration and discrimination on the test data. Conclusion: We developed a cardiovascular risk model that has very good predictive capacity and encompasses new variables. The score could be incorporated into clinical practice and utilised in a remote setting, without the need of including cholesterol. Future studies will focus on external validation across heterogeneous samples.

Related papers

• Detection of subclinical atherosclerosis by image-based deep learning on chest x-ray [86.38767955626179]
  Deep-learning algorithm to predict coronary artery calcium (CAC) score was developed on 460 chest x-ray. The diagnostic accuracy of the AICAC model assessed by the area under the curve (AUC) was the primary outcome.
  arXiv  Detail & Related papers  (2024-03-27T16:56:14Z)
• Survival modeling using deep learning, machine learning and statistical methods: A comparative analysis for predicting mortality after hospital admission [9.719996519981333]
  We conducted a comparative study of several survival analysis methods, including Cox proportional hazards (CoxPH), stepwise CoxPH, elastic net penalized Cox model, and GBM learning. As a case study, we performed a retrospective analysis of patients admitted through the emergency department of a tertiary hospital from 2017 to 2019. The results of the C-index indicate that deep learning achieved comparable performance, with DeepSurv producing the best discrimination.
  arXiv  Detail & Related papers  (2024-03-04T10:46:02Z)
• MedDiffusion: Boosting Health Risk Prediction via Diffusion-based Data Augmentation [58.93221876843639]
  This paper introduces a novel, end-to-end diffusion-based risk prediction model, named MedDiffusion. It enhances risk prediction performance by creating synthetic patient data during training to enlarge sample space. It discerns hidden relationships between patient visits using a step-wise attention mechanism, enabling the model to automatically retain the most vital information for generating high-quality data.
  arXiv  Detail & Related papers  (2023-10-04T01:36:30Z)
• DeepCOVID-Fuse: A Multi-modality Deep Learning Model Fusing Chest X-Radiographs and Clinical Variables to Predict COVID-19 Risk Levels [8.593516170110203]
  DeepCOVID-Fuse is a deep learning fusion model to predict risk levels in coronavirus patients. The accuracy of DeepCOVID-Fuse trained on CXRs and clinical variables is 0.658, with an AUC of 0.842.
  arXiv  Detail & Related papers  (2023-01-20T20:54:25Z)
• Clinical Deterioration Prediction in Brazilian Hospitals Based on Artificial Neural Networks and Tree Decision Models [56.93322937189087]
  An extremely boosted neural network (XBNet) is used to predict clinical deterioration (CD) The XGBoost model obtained the best results in predicting CD among Brazilian hospitals' data.
  arXiv  Detail & Related papers  (2022-12-17T23:29:14Z)
• SurvLatent ODE : A Neural ODE based time-to-event model with competing risks for longitudinal data improves cancer-associated Deep Vein Thrombosis (DVT) prediction [68.8204255655161]
  We propose a generative time-to-event model, SurvLatent ODE, which parameterizes a latent representation under irregularly sampled data. Our model then utilizes the latent representation to flexibly estimate survival times for multiple competing events without specifying shapes of event-specific hazard function. SurvLatent ODE outperforms the current clinical standard Khorana Risk scores for stratifying DVT risk groups.
  arXiv  Detail & Related papers  (2022-04-20T17:28:08Z)
• Identifying Ventricular Arrhythmias and Their Predictors by Applying Machine Learning Methods to Electronic Health Records in Patients With Hypertrophic Cardiomyopathy(HCM-VAr-Risk Model) [0.3811495093928132]
  This is the first application of machine learning for identifying hypertrophic cardiomyopathy patients with ventricular arrhythmias (VAr) using clinical attributes. We evaluated 93 clinical variables, of which 22 proved predictive of VAr. Our method identified 12 new predictors of VAr, in addition to 10 established SCD predictors.
  arXiv  Detail & Related papers  (2021-09-19T20:11:07Z)
• Development of a dynamic type 2 diabetes risk prediction tool: a UK Biobank study [0.8620335948752806]
  We developed a predictive 10-year type 2 diabetes risk score using 301 features from the UK Biobank dataset. A Cox proportional hazards model slightly overperformed a DeepSurv model trained using the same features. This tool can be used for clinical screening of individuals at risk of developing type 2 diabetes and to foster patient empowerment.
  arXiv  Detail & Related papers  (2021-04-20T16:37:26Z)
• Predicting cardiovascular risk from national administrative databases using a combined survival analysis and deep learning approach [0.3463527836552467]
  This study compared the performance of deep learning extensions of survival analysis models with traditional Cox proportional hazards (CPH) models. Deep learning models significantly outperformed CPH models on the basis of proportion of explained time-to-event occurrence. Deep learning models can be applied to large health administrative databases to derive interpretable CVD risk prediction equations.
  arXiv  Detail & Related papers  (2020-11-28T00:10:25Z)
• UNITE: Uncertainty-based Health Risk Prediction Leveraging Multi-sourced Data [81.00385374948125]
  We present UNcertaInTy-based hEalth risk prediction (UNITE) model. UNITE provides accurate disease risk prediction and uncertainty estimation leveraging multi-sourced health data. We evaluate UNITE on real-world disease risk prediction tasks: nonalcoholic fatty liver disease (NASH) and Alzheimer's disease (AD) UNITE achieves up to 0.841 in F1 score for AD detection, up to 0.609 in PR-AUC for NASH detection, and outperforms various state-of-the-art baselines by up to $19%$ over the best baseline.
  arXiv  Detail & Related papers  (2020-10-22T02:28:11Z)
• CovidDeep: SARS-CoV-2/COVID-19 Test Based on Wearable Medical Sensors and Efficient Neural Networks [51.589769497681175]
  The novel coronavirus (SARS-CoV-2) has led to a pandemic. The current testing regime based on Reverse Transcription-Polymerase Chain Reaction for SARS-CoV-2 has been unable to keep up with testing demands. We propose a framework called CovidDeep that combines efficient DNNs with commercially available WMSs for pervasive testing of the virus.
  arXiv  Detail & Related papers  (2020-07-20T21:47:28Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.